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Hexachlorobutadiene (HCBD), while not produced commercially in the United States, may be encoun-
tered as an unwanted by-product of certain processes associated with the chlorination of hydrocarbons.
Studies were conducted to assess the potential long-term toxicity of HCBD. In a reproduction study
conducted in rats, dose levels of20 or 2.0 mg/kg-day ofHCBD induced slight maternal toxicity (primarily
of the kidney) but caused no adverse effects on reproductive parameters-percent pregnancy and
neonatal survival/development. A decreased neonatal body weight was noted at the highest dose level of20
mg/kg-day of HCBD. No toxicologic effects were observed among the adults at a dose level of 0.2
mg/kg-day or among the neonates at dose levels of 0.2 or 2.0 mg/kg-day of HCBD.
In a chronic toxicity study in rats, ingestion of 20 mg/kg-day for up to 2 years caused multiple
toxicologic effects, primarily of the kidney, including the development of renal tubular adenomas and
adenocarcinomas. Ingestion ofthe intermediate dose level of2 mg/kg-day caused lesser degrees oftoxicity,
but no evidence of neoplasia. Ingestion of the lowest dose level of 0.2 mg/kg-day of HCBD caused no
effects that could be attributed to treatment. These data indicate a dose-response relationship for HCBD-
induced toxicity affecting primarily the kidney. HCBD-induced neoplasms occurred only at a dose level
higher than that causing discernible renal injury.
Hexachlorobutadiene, CC12=CCl-CCl=CC12
(HCBD) is encountered as an unwanted by-
product of certain processes associated with the
chlorination of hydrocarbons. Although HCBD is
not currently produced in the United States,
HCBD reportedly has been used in Russia as a
fumigant to treat grape phylloxera (1).
The acute toxicity data on HCBD have been re-
viewed (2). The acute oral LD50 has been reported
to be 90 mg/kg for the guinea pig (3), 87-116 mg/kg
for the mouse (2, 4) and 200-350 mg/kg for the rat
(2, 4). HCBD was reported to be the most toxic ofa
series ofchlorinated solvents in terms of acute oral
lethality to mice (5).
Dermal application of 126 mg/kg of HCBD was
lethal to ½ rabbits after 7 hr and 4/4 rabbits after 24
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hr (2). All rabbits survived the dermal application of
120 mg/kg for 4 hr or 63 mg/kg for 24 hr. A report in
the Russian literature suggested that neonatal rats
may be more sensitive to the acute lethal effect of
HCBD than adult rats. Deaths occurred among
newborn ofrats given a single subcutaneous dose of
20 mg HCBD/kg 3 months previously (6).
Single exposures to atmospheres containing
133-500 ppm HCBD for 4-7 hr caused the death of
some or all rats exposed; all rats survived exposure
to 161 ppm for 0.88 hr or 34 ppm for 3.5 hr (2). Most
guinea pigs and cats died subsequent to exposure to
161 ppm for 0.88 hr or 34 ppm for 7.5 hr (2). In
short-term repeated inhalation studies with HCBD
(7), daily 6-hr exposures to 25 ppm HCBD caused
respiratory difficulty, decreased weight gain and
pathologic injury to the tubular epithelium of the
kidneys; 12 daily 6-hr exposures to 100 ppm HCBD
caused more severe toxicity, including the death of
some rats. There was no evidence of toxicity with
15 daily 6-hr exposures to 10-5 ppm, except for
December 1977 49retarded weight gain in female rats'exposed to 10
ppm of HCBD. Another group (4) reported that
exposure to 0.024 mg HCBD/l. air ( 2.3 ppm) for 7
months (number of hours/day or number of
days/week not given) caused no alterations in mice
or rats.
In a previous 30-day toxicity study in our
laboratory, rats received HCBD in the diet at daily
dose levels ranging from I to 100 mg/kg (8). Renal
toxicity in the form of an increase in the kidney-
body weight ratio as well as renal tubular degenera-
tion, necrosis and regeneration occurred in rats re-
ceiving 30, 65 and 100 mg HCBD/kg-day. Other
adverse effects observed included decreased food
consumption and body weight gain at 10, 30, 65, and
100 mg/kg-day, minimal hepatocellular swelling at
100 mg/kg-day and hemoconcentration at 10, 30, 65,
and 100 mg/kg-day. No adverse effects were ob-
served among those receiving 3 mg/kg-day. The
kidney was the organ most sensitive to the deleteri-
ous effects of HCBD. In a reproduction study (9)
conducted in our laboratory, maintenance of adult
Japanese quail for a period of90 days on diets con-
taining HCBD concentrations up to 30 ppm (about
5 mg/kg-day) had no deleterious effect on reproduc-
tion.
Based on the above review ofthe available toxic-
ity data on HCBD, it became apparent that there
was a need for data to more adequately assess the
potential toxicity of HCBD, especially in regard to
chronic toxicity. Thus, our laboratory conducted
additional toxicity studies with HCBD. The results
of one of these studies dealing with the lifetime in-
gestion by rats ofdiets containing HCBD has been
reported previously in detail (10). The results of a
reproduction study on rats ingesting diets contain-
ing HCBD has also been reported in detail (11).
This paper herein reviews the highlights of our
studies reported previously in detail (10, 11) as well
as some additional data on the acute oral lethality of
HCBD in neonatal versus adult rats.
Materials and Methods
Sample of HCBD
The sample of HCBD used in these toxicity
studies was supplied by the Dow Chemical Com-
pany, Midland, Michigan, and was described as
99.00% HCBD.
Acute Lethality Study in Rats
HCBD was given as a corn oil solution by oral
gavage to Sprague-Dawley neonatal rats (21-22
days of age) and adult rats. The test solution was
prepared so that a volume of 10 ml/kg provided the
desired dose of HCBD. There were five to six
rats/dose level. The rats were observed until they
were no longer showing signs of toxicity. The LD50
value was calculated according to a published pro-
cedure (12).
Reproduction Study in Rats
The details of this study have been given in the
previously cited paper (11). Groups of male and
female Sprague-Dawley rats were maintained on
diets supplying 0, 20, 2, or 0.2 mg/kg-day of HCBD
for 90 days prior to mating, 15 days during mating,
and, subsequently, throughout gestation and lacta-
tion. After 21 days of lactation, the dams and their
young were killed and given a gross pathologic ex-
amination. Various organs from each adult rat were
weighed and microscopic examination was con-
ducted on tissues for all organ systems. Preterminal
hematologic and urinary analyses were conducted
on adult males and females. Terminal serum sam-
ples were collected from the adult males and
females for determination of blood urea nitrogen
(BUN), creatinine, and serum glutamic pyruvic
transaminase (SGPT) activity.
The reproductive parameters assessed in this
study are listed in Table 3 below. In addition, the
weanlings of each litter were subjected to a gross
autopsy examination, with microscopic examina-
tion of liver, kidney, spleen, heart, lung and testes
from males and females on the control and top dose
levels. Statistical evaluation ofreproductive indices
were made by the Fisher's Exact Probability Test
(13). Body organ weight data were analyzed by an
analysis ofvariance and Dunnett's Test (14). Level
of significance was p < 0.05.
Chronic Dietary Study in Rats
In this study, male and female Sprague-Dawley
rats were maintained on diets containing HCBD for
the duration of their lifetime. Specific details have
been given in the previously cited publication (10).
The rats were maintained on diets supplying 0, 20,
2.0, or 0.2 mg HCBD/kg-day for up to 24 months.
Group sizes were 39-40 rats/sex/dose level plus
90/sex for controls. Parameters monitored at vari-
ous intervals included appearance and demeanor,
body weights, food consumption, hematologic and
urine analyses, urinary prophyrins and serum clini-
cal chemistry (BUN), serum alkaline phosphatase
(AP) and SGPT activity. All rats dying or culled
during the study were subjected to gross pathologic
examination, with subsequent microscopic exami-
nation on tissues from all the rats.
Terminal necropsy examination (after 22 months
for males, 24 months for females) included determi-
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and testes plus gross and microscopic examination
of tissues of all rats. Resultant data were analyzed
statistically by an analysis of variance and
Dunnett's Test (14), except for tumor data, which
were analyzed with Fisher's Exact Probability Test
(13). Level of significance was p < 0.05.
Results
The results of the acute oral lethality study are
listed in Table 1. The LD50 of HCBD in adult male
and female rats following a single oral dose was 580
(504-667) mg/kg and 200-400 mg/kg, respectively.
The LD50 in 21-day-old male and female weanling
rats was 64 (46-91) mg/kg and 46 (26-81) mg/kg,
respectively. The majority of the deaths occurred
on the second or third day after dosage with some
deaths as late as 17 days after dosage.
Table 1. Results of acute oral lethality study of HCBD
in weanling and adult rats.
LD50 + 95% confidence limits, mg/kg
Age of rats Male Female
Adult 580 (504-667) 200-400
(LDso and confi-
dence limits not
calculable)
21-22 days 65 (46-91) 46 (26-81)
Reproduction Study in Rats
Detailed results have been included in the paper
cited previously (11). These results are summarized
in Tables 2 and 3 on the basis of comparison with
control data. Adult male and female rats ingesting
the high dose level of 20 mg/kg-day of HCBD
showed multiple toxicologic effects, including de-
creases in food consumption and body weight gain.
Terminal kidney weights ofthese males and females
were increased, as were the liver weights of the
males. Pathologic examination revealed renal tubu-
lar epithelial degeneration and regeneration in both
males and females ingesting 20 mg/kg-day of
HCBD. Adult rats ingesting the intermediate dose
level of 2 mg/kg-day of HCBD were comparable to
controls, except for a much lower incidence of the
renal tubular histopathologic changes noted at the
high dose level. Adult rats ingesting 0.2 mg/kg-day
of HCBD had no observations considered related
to treatment.
The parameters used to assess the reproductive
performance of the rats are summarized in Table 3.
The ingestion of 20, 2, or 0.2 mg/kg-day of HCBD
had no effect on the percent pregnancy, gestation
survival, neonatal survival, neonatal sex ratio or
morphologic alterations in neonates. Neonatal body
weights were unaffected except for a decreased
body weight on day 21 for the neonates of the high
dose level, 20 mg/kg-day of HCBD.
Results of Chronic Dietary Study in Rats
Detailed data on the results of the study have
been included in the publication cited previously
(10). These results are summarized in Table 4.
Lifetime ingestion of the highest dose level of 20
mg/kg-day of HCBD caused multiple toxicologic
effects. This included increased mortality (males),
decreased body weight gain (males and females),
increased urinary excretion of coproporphyrin
(males and females), and increased terminal weights
Table 2. Observations on adult rats used in reproduction study with HCBD
(interpretation comparative to control data).
Comparison with controls"
HCBD 20 mg/kg-day HCBD 2 mg/kg-day HCBD 0.2 mg/kg-day
Parameters M F M F M F
Clinical observations
Food consumption DEC DEC
Body weight gain DEC DEC
Clinical chemistry
BUN DEC* DEC* - -
SGPT
Creatinine
Terminal organ weights
Kidney INC INC
Liver INC
Pathology examination Renal tubular Low incidence
degeneration and of same
regeneration
aCode: (-) comparable to control data; (*) considered to be ofquestionable toxicologic significance; (INC) or (DEC)
indicates parameter was increased or decreased relative to control data.
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(interpretation comparative to control data).
Comparison with controlsa
Reproductive parameters HCBD 20 mg/kg-day HCBD 2 mg/kg-day HCBD 0.2 mg/kg-day
Pregnancy rate (%)
Gestation survival
24 hr survival
7-Day survival
14-Day survival
21-Day survival
Neonatal body weight
Day 1
Day 7
Day 14
Day 21 DEC
Sex Ratio M/F
Gross autopsy examination
of weanlings
Histopathological examination
of weanlings Not examined
aSee Table 2.
Table 4. Results of chronic dietary study with HCBD in rats (interpretation comparative to control data).
Comparison with controla
HCBD 20 mg/kg-day HCBD 2 mg/kg-day HCBD 0.2 mg/kg-day
Parameter M F M F M F
Mortality INC
Body weight gain DEC DEC
Food consumption
Hematology (RBC) DECb
(others unaffected)
Urinalysis
Urine concentration test
Urinary coproporphyrin INC INC INC
(others unaffected)
Clinical chemistry
BUN - -
SGPT
SAP
Terminal organ weights,
kidneys INC INC
Autopsy examination Kidney nodules
Histopathological examination Kidney neoplasia
Kidney hyperplasia Kidney hyperplasia
aSee Table 2.
bPossible secondary to renal toxicity.
Table 5. Renal tubular neoplasms in chronic dietary study with HCBD in rats.
Renal
HCBD dose Renal tubular adenoma tubular adenocarcinoma Total
levels, Number Number Number
mg/kg-day Sex of rats % of rats of rats % of rats of rats % of rats
0 M 1/90 1.7 0/90 0 1/90 1.1
20 2/39 5.1 9/39 18 9/39 23.la
2.0 0/40 0 0/40 0 0/40 0
0.2 0/40 0 0/40 0 0/40 0
0 F 0/90 0 0/90 0 0/90 0
20 3/40 7.5 3/40 7.5 0/40 15a
0.2 0/40 0 0/40 0 0/40 0
0.2 0/40 0 0/40 0 0/40 0
ap < 0.05.
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Pathologic examination revealed changes in the
kidneys, including hyperplasia and neoplasia of
renal tubular epithelium. Some of the neoplasms
were noted grossly as nodules in the kidneys. These
nodules in the kidneys were microscopically diag-
nosed as renal tubular adenomas or adenocar-
cinomas, some of which metastasized to the lungs.
Approximately 23% of the males and 15% of the
females from the 20 mg/kg-day dose level had renal
tubular neoplasms (Table 5).
At the intermediate dose level of2.0 mg/kg-day of
HCBD, findings considered related to treatment
were limited to an increased urinary excretion of
coproporphyrin (females only) and increased
hyperplasia of renal tubular epithelium. This inter-
mediate dose level of2 mg/kg-day of HCBD caused
no neoplasms considered related to treatment.
Lifetime ingestion of the lowest dose level of 0.2
mg/kg-day of HCBD caused no discernible ill ef-
fects in any of the parameters monitored in this
study.
Discussion
These recent studies reveal several pertinent ob-
servations on the toxicity of HCBD. On an acute
basis, the weanling rat appears to be substantially
more sensitive than the adult rat to a single oral
dose of HCBD.
In the reproduction study, dose levels of20 or 2.0
mg/kg-day of HCBD induced maternal toxicity
(primarily of the kidney) but caused no adverse ef-
fects on reproductive parameters-percent preg-
nancy and neonatal survival/development. A de-
creased neonatal body weight on day 21 was noted
only at the highest dose level of 20 mg/kg-day of
HCBD. No toxicological effects were observed
among the adults at a dose level of0.2 mg/kg-day or
among the neonates at dose levels of 0.2 or 2.0
mg/kg-day of HCBD.
In the chronic dietary study, as in shorter-term
studies conducted previously with HCBD, the kid-
ney appeared to be the primary target organ. Inges-
tion of 20 mg/kg-day of HCBD for up to 2 years
caused multiple toxicologic effects, including de-
creased body weight gain, increased mortality, in-
creased urinary excretion of coproporphyrin, in-
creased weights of kidneys, increased renal tubular
epithelial hyperplasia, and renal tubular adenomas
and adenocarcinomas, some of which metastasized
to the lungs.
Ingestion of the intermediate dose level of 2
mg/kg-day ofHCBD for up to 2 years caused lesser
degrees oftoxicity, including an increase in urinary
coproporphyrin excretion and an increase in renal
tubular epithelial hyperplasia. The fact that urinary
excretion of coproporphyrin was increased at this
dose level which produced no neoplasms may indi-
cate the usefulness of this parameter as a biological
monitor when included in a medical surveillance
program for workers exposed to HCBD.
Ingestion of the lowest level dose of 0.2 mg/kg-
day of HCBD for up to 2 years caused no effects
that could be attributed to treatment. Whereas the
intermediate dose level of 2.0 mg/kg-day caused a
slight degree ofrenal toxicity, the highest dose level
of 20 mg/kg-day for up to 2 years caused multiple
and substantial toxicologic effects, including renal
tubular neoplasms. Thus, these data indicate a
clear-cut dose-response relationship for HCBD-
induced toxicity affecting primarily the kidney.
HCBD-induced renal neoplasms occurred only at a
dose level higher than that causing discernible renal
injury.
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